Lightnews — Scholar-powered news

Jill Feldman @jillfeldman4.bsky.social · Jul 29

Deadline is approaching!

Are you doing research in #EGFR+ #lungcancer — OR mentoring someone who is — submit an abstract to the EGFR Resisters Research Summit
Concepts welcome
Deadline-August 8.
Submit Abstract - ceconcepts.com/egfr-summit

#NSCLC #ThoracicOnc #HOFellows #EGFRResisters
#OncoAlert

2

Reposted by Jill Feldman

ASCO ASPIRE COP: Alliance for Support and Prevention of irAEs @aspire-cop.bsky.social · May 15

Heading to #ASCO25 this year? Be sure to join us for the first ever #ASPIRE Community of Practice on Friday, May 30th: 4-6pm CST in E253cd. We have a great agenda and opportunity to connect with other #irAE aficionados @ascocancer.bsky.social @funchainmd.bsky.social www.asco.org/annual-meeti...

1 4 9

Jill Feldman @jillfeldman4.bsky.social · May 15

I sometimes feel like people are sick and tired of me being sick and tired

a baby is sitting on a couch and making a face

ALT: a baby is sitting on a couch and making a face

media.tenor.com

1 2

Reposted by Jill Feldman

Eric Roeland @ericroeland.bsky.social · May 13

Sick and tired of being sick and tired? Thanks @funchainmd.bsky.social & Afreen Shariff for the chance to discuss cancer-related fatigue @ascocancer.bsky.social @americancancersoc.bsky.social @pallonccop.bsky.social @oncoalert.bsky.social @aspire-cop.bsky.social podcasts.apple.com/us/podcast/e...

Episode 30: Fatigue and Cancer- Symptom of cancer or a sign of a toxicity?

Podcast Episode · Checkpoint NOW · 05/09/2025 · 42m

podcasts.apple.com

2 4 6

Reposted by Jill Feldman

ASCO Palliative Oncology Community of Practice (PallOncCoP) @pallonccop.bsky.social · Nov 23

Welcome #pallonc #supponc folks to the official Blue Sky account for ASCO supported #PallOncCoP. Please follow for official Zoom meeting events, in-person conference meet ups like pic #ASCO24 and sharing the latest science in comfort and cure.

10 17

Reposted by Jill Feldman

TingTing Zhang @tingtingzhang.bsky.social · Mar 18

I will co-chair with Prof Maryam Lustberg on June 26th AM
"Workshop 1: Partnering with patients in managing chronic toxicities of cancer and its treatment."
bringing together multidisciplinary professionals, cancer patients, survivors and carers to compare best practices for management toxicities.

1 5 15

Jill Feldman @jillfeldman4.bsky.social · Feb 19

My Guiding Compass in Advocacy:

Speak up, but do it with respect.
Challenge, but do it with understanding.
And always push forward with purpose — Real change happens through conversation, not confrontation.

I was 28 when my mom died, but her profound wisdom always guides me 💙

1 5 28

Reposted by Jill Feldman

Lung Cancer Research Foundation @lcrf.org · Jan 23

Jill Feldman wrote a powerful article for @curetoday.bsky.social about the #LungCancerGeneticsStudy – a collaboration between nearly two dozen #LungCancer organizations and 23andme to uncover the genetic risks of lung cancer. Read it at: www.curetoday.com/view/the-pow...

@jillfeldman4.bsky.social

The Power of Unity: Why the Lung Cancer Genetics Study Matters

The Lung Cancer Genetics Study, a collaboration between lung cancer advocacy organizations, aims to explore the genetics of lung cancer

www.curetoday.com

6 14

Reposted by Jill Feldman

TingTing Zhang @tingtingzhang.bsky.social · Jan 24

ASCO has a palliative care community of practice in which a patient advocate pillar was organized with @jillfeldman4.bsky.social, Ameish, and I as members. I have served since September 2023 as the lead and will hand over the role later this year.

2 1 4

Reposted by Jill Feldman

TingTing Zhang @tingtingzhang.bsky.social · Jan 24

Please email [email protected] to be added to the listserv.

1 1

Jill Feldman @jillfeldman4.bsky.social · Jan 16

Words Matter isn't just a catchphrase. It is a simple yet profound truth when talking about #lungcancer

Thank you, Drs Jamie Ostroff & Smita Banerjee, for your efforts to develop a training that offers strategies for empathic communication to ⬇️ stigma bit.ly/4gWH1Si

#LCSM #EndStigmaNow

Helping Health Professionals Reduce Lung Cancer Stigma

Researchers have developed a training program to help health providers reduce lung cancer stigma and have launched a clinical trial to test the training.

bit.ly

2 7

Jill Feldman @jillfeldman4.bsky.social · Jan 14

THIS!

Easy-to-use, available regimen significantly ⬇️ frequency & severity of Grade 2+ AEs SOC for patients on first-line Ami/Lazer.

Like “Stay ahead of the pain,” “Stay ahead of the side effects” boosts QOL & ⬇️ dose interrupt/discontine—a win for everyone. 👏
#LCSM #SuppOnc
bit.ly/4jiKwUz

COCOON study meets primary endpoint demonstrating statistically significant and clinically meaningful reduction in dermatologic reactions with easy-to-use prophylactic regimen for patients with EGFR-m...

bit.ly

3 12

Jill Feldman @jillfeldman4.bsky.social · Dec 24

What a pleasure it was to meet Donghoon Shin! His passion and desire to learn from patient advocates was genuine and impressive. The future of #lungcancer research is bright😎
#LCSM #EGFR

Ivy Riano, MD @ivyrianomd.bsky.social · Dec 15

Congrats Donghoon Shin on receiving an honorable mention at the @EGFRSummit Your research and passion for the field are truly impressive #ProudMentor

Huge shoutout to @EGFRResisters for giving trainees a platform to showcase their work! #LCSM 🙌🏼 @jillfeldman4.bsky.social

1 8

Reposted by Jill Feldman

Advocates for Collaborative Education @advocatecollab.bsky.social · Dec 16

ICYMI
"We must rethink how we define progress in oncology"
#Oncosky #Cansky #Pallonc

Jill Feldman @jillfeldman4.bsky.social · Nov 25

Innovation shouldn't come at the expense of patient-centered care!
Great article about prioritizing what matters to patients (QOL/OS/⬇️ burdens). It underscores palliative care being viewed as essential, not ancillary.
We must rethink how we define progress in #oncology
#pallonc #LCSM
bit.ly/3OJQuQB

The trade-off between accelerated cancer drug approvals and patient preferences

Cancer care stands at a critical juncture where the urgency of rapid drug approvals must be balanced against the need for enduring patient-centric benefits. Robin Forrest and colleagues1 conducted a d...

bit.ly

2 5

Reposted by Jill Feldman

Laronica Conway @ronilynnwrites.bsky.social · Nov 25

“The most common cause of death from cancer is from lung cancer…yet just 16% of eligible people get screened for lung cancer, far lower than screening rates for colorectal or breast cancer. “ #medsky ktul.com/news/nation-...

More people surviving lung cancer, but work remains in screening and biomarker testing

The American Lung Association has released its annual "State of Lung Cancer" report.

ktul.com

1 5 14

Jill Feldman @jillfeldman4.bsky.social · Nov 25

Innovation shouldn't come at the expense of patient-centered care!
Great article about prioritizing what matters to patients (QOL/OS/⬇️ burdens). It underscores palliative care being viewed as essential, not ancillary.
We must rethink how we define progress in #oncology
#pallonc #LCSM
bit.ly/3OJQuQB

The trade-off between accelerated cancer drug approvals and patient preferences

Cancer care stands at a critical juncture where the urgency of rapid drug approvals must be balanced against the need for enduring patient-centric benefits. Robin Forrest and colleagues1 conducted a d...

bit.ly

2 21 45

Jill Feldman @jillfeldman4.bsky.social · Nov 24

great idea!

1 2

Reposted by Jill Feldman

Dr Jaishree Bhosle @jia-b.bsky.social · Nov 21

Only this week a patient asked me if thought she was foolish for declining further treatment. She is not foolish, it is the right decision for her.

Jill Feldman @jillfeldman4.bsky.social · Nov 21

It was an honor to co-author this article
bit.ly/40WN9Vr
It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face.
It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care.
#LCAM #LCSM

Lung cancer—a one-way ticket

The physician’s duty is not to stave off death or return patients to their old lives, but to take into our arms a patient and family whose lives have disin

bit.ly

2 9

Jill Feldman @jillfeldman4.bsky.social · Nov 21

It was an honor to co-author this article
bit.ly/40WN9Vr
It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face.
It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care.
#LCAM #LCSM

Lung cancer—a one-way ticket

The physician’s duty is not to stave off death or return patients to their old lives, but to take into our arms a patient and family whose lives have disin

bit.ly

1 14 33

Jill Feldman @jillfeldman4.bsky.social · Nov 21

Working on the #ASCO #SCLC guidelines, published in 2023, was disheartening, but working on the rapid update (based on #ASCO24 data) left me emotional.
This update represents hope & progress for patients who have waited far too long. ascopubs.org/doi/10.1200/...
#LCSM

Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update | Journal of Clinical Oncology

ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an e...

ascopubs.org

2 9 38

Jill Feldman @jillfeldman4.bsky.social · Nov 20

Looking forward to it!

1 2

Reposted by Jill Feldman

Dr Joseph McCollom DO @realbowtiedoc.bsky.social · Nov 20

Today's the day! Our last PallOncCoP meeting of 2024! Don't miss it. Not too late to DM📨 for Zoom 🔗. Always stay in the know by sending your prof email to [email protected] to be added to our listserv.

@darcyburbage.bsky.social
@tingtingzhang.bsky.social
@jillfeldman4.bsky.social

sarahlowry.bsky.social @sarahlowry.bsky.social · Nov 17

Looking forward to sharing our experience next week!

Dr Joseph McCollom DO @realbowtiedoc.bsky.social · Nov 17

Join our #PallOncCoP next Wednesday for an interdisciplinary conversation on mentorship feat @ericroeland.bsky.social and @sarahlowry.bsky.social. DM for details or email [email protected] to be added to the listserv.
hapc hpm #pallonc #supponc CanSky MedSky

2 2 5

Jill Feldman @jillfeldman4.bsky.social · Nov 15

The #lungcancer screening team at RushCancer Center
has had a 50% uptake in screening for the 3rd year! Congratulations to Annie and the team, and thank you for your tireless efforts to raise awareness about lung cancer screening!
#LCSM #LCAM #EarlyDetectionSavesLives

1 4 46

Jill Feldman @jillfeldman4.bsky.social · Nov 14

Great episode Dr Ross Camidge's podcast #HowThisIsBuildingMe with pharmacologist Dr. Zirkelbach (FDA Onc) on drug dev & her focus on #PROs for best outcomes w/fewest AEs

I always learn, but still have questions about #ProjectOptimus
bit.ly/48RlOpz
#LCAM #LCSM #TheRightDose
@itsnotpink.bsky.social

FDA Involvement in Dose Optimization Through Project Optimus Drives a Patient-Focused Oncology Pharmacology Career: With D. Ross Camidge, MD, PhD; and Jeanne Fourie Zirkelbach, PhD

Drs Camidge and Zirkelbach discuss Zirkelbach's first pharmacokinetics forays and her involvement with reforming dose optimization in drug development.

bit.ly

5 17

Jill Feldman @jillfeldman4.bsky.social · Nov 13

📢 The @ASCO released updated living guidelines for treating stage IV #NSCLC with driver alterations! ascopubs.org/doi/10.1200/....

This is no easy feat, but it was an honor to work alongside exceptional experts dedicated to providing the most up-to-date, evidence-based guidance.
#LCSM #LCAM

11 31